Main Menu

Day: 12 October 2018

Widows switches fund

BlackRock wins slice of Scottish Widows mandate

Scottish Widows
Widows: unhappy with Standard Life Aberdeen merger Scottish Widows has switched part of a controversial mandate from Standard Life Aberdeen to BlackRock which will now manage £30 billion of assets. ARead More

Leaving post after 15 years

Watt stepping down as IoD Scotland director

David Watt is leaving the IoD in Scotland after 15 years
David Watt is stepping down as executive director of the IoD in Scotland    David Watt, executive director of the Institute of Directors in Scotland is to step down fromRead More

Tycoon pays £95m for store

Ashley ready to roll out ‘Harrods’ plan for Glasgow

House of Fraser Glasgow
Enhancement in store: Ashley will invest in Glasgow outlet (pic: Terry Murden)   Mike Ashley has paid £95m for the House of Fraser store in Glasgow and hinted at turningRead More

As Trump blasts 'crazy' Fed

Investors pull back from interest rate rise rout

stock exchange
Close: Equity markets staged a recovery, following a two-day rout, easing worries among investors. The Nasdaq was the standout performer on Wall Street, jumping 2.3% to 7,496.89 as investors decidedRead More

Savings appointment

McInnes takes chair of key ABI committee

Susan McInnes of SLAL
The Association of British Insurers (ABI) has appointed Susan McInnes, CEO of Standard Life Assurance (SLAL) and director of open business at Phoenix Group, as chairman of its long-term savingsRead More

Poor awareness of devolved powers

Public unclear over which parliament is raising taxes

Charlotte Barbour, Jim Robertson and Joanne Walker
Taxing issues: Charlotte Barbour, Jim Robertson and Joanne Walker of the Scottish Taxes Policy Forum (pic: Terry Murden)   Confusion over the Scottish tax system is rife, with the publicRead More

Firm tackling serious disease

Par Equity and SIB back Censo’s stem cell research

Paul Munn
Venture capital firm Par Equity and the Scottish Investment Bank (SIB) have invested £1.3m in a rapidly growing Scottish stem-cell research company helping pharmaceutical giants develop treatments for diseases includingRead More

As I See It

We may have to get used to having No Deal

Theresa May at Downing St after Syria attack
A crucial week of Brexit talks lies ahead and we must brace ourselves for the outcome, says BRIAN MONTEITH